SCHEMBL1886479

SCHEMBL1886479

Cc1cccn2c(=O)c(O)c(C(=O)NCc3ccc(F)cc3)nc12

nearest known ligand 0.74

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.57
RXFP1 Q9HBX9 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
KCNE1 P15382 1/20 0.48
CCR1 P32246 1/20 0.48
KCNQ1 P51787 1/20 0.48
ERCC1 P07992 1/20 0.46
FEN1 P39748 1/20 0.46
ERCC4 Q92889 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1877321 0.88 SMN1; SMN2 (0.49) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL4555867 0.88 SMN1; SMN2 (0.48) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL4637379 0.88 SMN1; SMN2 (0.48) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL12952653 0.87 SMN1; SMN2 (0.47) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL1881737 0.87 SMN1; SMN2 (0.47) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL1874288 0.87 SMN1; SMN2 (0.47) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL1881581 0.85 KCNH2 (0.46) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL1881234 0.84 KCNH2 (0.46) THRBSMN1; SMN2KCNE1CCR1KCNQ1
SCHEMBL1875688 0.83 HDAC1 (0.49) SMN1; SMN2ERCC1FEN1ERCC4MEN1
SCHEMBL1877381 0.83 SMN1; SMN2 (0.46) RXFP1SMN1; SMN2ERCC1FEN1ERCC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937678-B1 HIV INTEGRASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2011-07-27 EP claimed
US-7939537-B2 HIV integrase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2011-05-10 US claimed